Find your path to Nathan
262 people in our graph share verified history with Nathan — schools, employers, funds. One of them is your warm intro.
Katrin GeyskensunlockedNathan: together at The University of Chicago Booth School of Business (1995–1996)
Nathan: together at Rubius Therapeutics
×4Nathan: together at Huron Consulting Group
×5Nathan: together at University of Connecticut
Executive at Entrada Therapeutics, Inc.
Intro paths
→
In turn, Nathan can intro founders to Entrada Therapeutics, Inc.'s investors below.
President and Chief Operating Officer at Entrada Therapeutics, Inc.
Intro paths
→
In turn, Nathan can intro founders to Entrada Therapeutics, Inc.'s investors below.
Experience
- Entrada TherapeuticsPresident and Chief Operating Officercurrent2024 — presentBoston, Massachusetts, United States
- Entrada TherapeuticsChief Operating Officer2019 — 2023
- Rubius TherapeuticsSenior Vice President, Corporate Development2016 — 2019Cambridge, MA
- Huron Consulting GroupManaging Director2014 — 2016Cambridge, MA
- The Frankel Group LLCManaging Director1997 — 2014
- Ernst & YoungSenior Consultant1996 — 1997Greater Boston
Skills & more
Business StrategyHealthcare
From Nathan's professional profile.
Frequently asked questions
- Who is Nathan J. Dowden?
- President and Chief Operating Officer at Entrada Therapeutics, Inc.
- Where does Nathan J. Dowden work?
- Nathan J. Dowden is Executive at Entrada Therapeutics, Inc. and President and Chief Operating Officer at Entrada Therapeutics, Inc..
- Where did Nathan J. Dowden go to school?
- Nathan J. Dowden studied at The University of Chicago Booth School of Business (MBA, Finance); University of Connecticut (BS, Finance).
Same school
Also attended The University of Chicago Booth School of Business942
Prashant ShahPartner at Monta Vista CapitalNoorPartner at Clear VenturesTinaInvestments & Portfolio Services Team Member at Clear VenturesKatrin GeyskensExecutive Director at Capricorn Venture PartnersBill PescatelloInvestor at LightbankGlebFounder and Managing Partner at iTech Capital
+ 936 more
Also attended University of Connecticut179
Amy ErrettVenture partner at True Ventures and founding CEO of Madison ReedKevin C. WangPrincipal at .406 VenturesRay UpdykeSVP, Finance, Operations at Alpaca VCGenene MorrisEditorial Director at Red Cell IncubationIveya SlavovaFund Accountant at PeakSpan Capital PartnersJinlin WangPartner at Foothill Ventures
+ 173 more
Shared employers
Also worked at Entrada Therapeutics10
Kush M ParmarManaging Partner at 5AM VenturesMax FarinaPrincipal at 5AM VenturesJackson SaundersInvestor at Cybernetix VenturesLauren MifflinPrincipal of Company Creation at Frazier Life SciencesDr Arjun GoyalInvestment committee member at Tin Alley VenturesJason RuthPartner at MRL Ventures Fund
+ 4 more
Also worked at Rubius Therapeutics6
Noubar AfeyanInvestor at Flagship PioneeringChris CarpenterExecutive Partner, Private Equity at Sofinnova VenturesAvak KahvejianGeneral Partner at Flagship PioneeringROGER POMERANTZDirector at VerImmuneKris ElverumFounder at ロゴマーク：AIRNAPablo J. CagnoniPresident, Incyte and Global Head of R&D at Incyte Corporation
Also worked at Huron Consulting Group37
Margaret Gaby MalonePartner at Flare Capital PartnersIsaac ZikeManaging Director at RiverVest Venture PartnersKaumudh SindeAnalyst at Arthur VenturesEileen WarisPrincipal — Ventures at Energize VenturesCourtney SawatzkeEarly-stage Investor at Active PartnersDavid YooPrincipal at Struck Capital
+ 31 more
Also worked at The Frankel Group LLC5
Ido KaminskyDirector, Technology and Venture Development at Toronto Innovation Acceleration PartnersPaul J. HaddenSenior Vice President, Investments and Business Development at Ligand PharmaceuticalsEmily MinkowVenture Partner at RA CapitalBrad SitkoChief Investment Officer at Xoma NASDAQ: XOMA www.xoma.comMatt TindallFounder at Flightpath
